Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. May 15, 2024; 16(5): 1908-1924
Published online May 15, 2024. doi: 10.4251/wjgo.v16.i5.1908
Published online May 15, 2024. doi: 10.4251/wjgo.v16.i5.1908
Figure 3 Efficiency of centrosome-related signature.
A: Kaplan-Meier plotter showed that a high-risk centrosome-related signature (CRS) was significantly related to poor survival in the training dataset, i.e., divided The Cancer Genome Atlas-Colon adenocarcinoma (TCGA-COAD) cohort; B-D: Kaplan-Meier plotter displayed that a high-risk CRS was significantly related to poor survival in the testing dataset, i.e., divided TCGA-COAD cohort, whole TCGA-COAD cohort, and GSE103479, respectively; E-H: Heat maps of CRS in the above-mentioned training dataset and three testing datasets; I-L: Receiver operating characteristic curves for 1-, 3-, and 5-year overall survival in the above-mentioned training dataset and three testing datasets.
- Citation: Wang HY, Diao Y, Tan PZ, Liang H. Four centrosome-related genes to predict the prognosis and drug sensitivity of patients with colon cancer. World J Gastrointest Oncol 2024; 16(5): 1908-1924
- URL: https://www.wjgnet.com/1948-5204/full/v16/i5/1908.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i5.1908